Long-term outcome of mild mesial temporal lobe epilepsy

Neurology ◽  
2016 ◽  
Vol 86 (20) ◽  
pp. 1904-1910 ◽  
Author(s):  
Angelo Labate ◽  
Umberto Aguglia ◽  
Giovanni Tripepi ◽  
Laura Mumoli ◽  
Edoardo Ferlazzo ◽  
...  
Epilepsia ◽  
2017 ◽  
Vol 58 (8) ◽  
pp. 1473-1485 ◽  
Author(s):  
Bertrand Mathon ◽  
Franck Bielle ◽  
Séverine Samson ◽  
Odile Plaisant ◽  
Sophie Dupont ◽  
...  

2005 ◽  
Vol 103 (5) ◽  
pp. 401-412 ◽  
Author(s):  
Sandeep Mittal ◽  
José L. Montes ◽  
Jean-Pierre Farmer ◽  
Bernard Rosenblatt ◽  
François Dubeau ◽  
...  

PLoS ONE ◽  
2016 ◽  
Vol 11 (7) ◽  
pp. e0159464 ◽  
Author(s):  
Tsugiko Kurita ◽  
Kotaro Sakurai ◽  
Youji Takeda ◽  
Toru Horinouchi ◽  
Ichiro Kusumi

2018 ◽  
Vol 129 (1) ◽  
pp. 174-181 ◽  
Author(s):  
Christian Dorfer ◽  
Thomas Czech ◽  
Susanne Aull-Watschinger ◽  
Christoph Baumgartner ◽  
Rebekka Jung ◽  
...  

OBJECTIVEThe aim of this study was to present long-term seizure outcome data in a consecutive series of patients with refractory mesial temporal lobe epilepsy primarily treated with transsylvian selective amygdalohippocampectomy (SAHE).METHODSThe authors retrospectively analyzed prospectively collected data for all patients who had undergone resective surgery for medically refractory epilepsy at their institution between July 1994 and December 2014. Seizure outcome was assessed according to the International League Against Epilepsy (ILAE) and the Engel classifications.RESULTSThe authors performed an SAHE in 158 patients (78 males, 80 females; 73 right side, 85 left side) with a mean age of 37.1 ± 10.0 years at surgery. Four patients lost to follow-up and 1 patient who committed suicide were excluded from analysis. The mean follow-up period was 9.7 years. At the last available follow-up (or before reoperation), 68 patients (44.4%) had achieved an outcome classified as ILAE Class 1a, 46 patients (30.1%) Class 1, 6 patients (3.9%) Class 2, 16 patients (10.4%) Class 3, 15 patients (9.8%) Class 4, and 2 patients (1.3%) Class 5. These outcomes correspond to Engel Class I in 78.4% of the patients, Engel Class II in 10.5%, Engel Class III in 8.5%, and Engel Class IV in 2.0%. Eleven patients underwent a second surgery (anterior temporal lobectomy) after a mean of 4.4 years from the SAHE (left side in 6 patients, right side in 5). Eight (72.7%) of these 11 patients achieved seizure freedom.The overall ILEA seizure outcome since (re)operation after a mean follow-up of 10.0 years was Class 1a in 72 patients (47.0%), Class 1 in 50 patients (32.6%), Class 2 in 7 patients (4.6%), Class 3 in 15 patients (9.8%), Class 4 in 8 patients (5.2%), and Class 5 in 1 patient (0.6%). These outcomes correspond to an Engel Class I outcome in 84.3% of the patients.CONCLUSIONSA satisfactory long-term seizure outcome following transsylvian SAHE was demonstrated in a selected group of patients with refractory temporal lobe epilepsy.


Epilepsia ◽  
2009 ◽  
Vol 50 (9) ◽  
pp. 2061-2071 ◽  
Author(s):  
Zdeněk Vojtěch ◽  
Vilibald Vladyka ◽  
Miroslav Kalina ◽  
Evžen Nešpor ◽  
Kateřina Seltenreichová ◽  
...  

2009 ◽  
Vol 110 (6) ◽  
pp. 1135-1146 ◽  
Author(s):  
Alaa Eldin Elsharkawy ◽  
Abdel Hamid Alabbasi ◽  
Heinz Pannek ◽  
Falk Oppel ◽  
Reinhard Schulz ◽  
...  

Object The aim of this study was to evaluate the long-term efficacy of temporal lobe epilepsy (TLE) surgery and potential risk factors for seizure recurrence after surgery. Methods This retrospective study included 434 consecutive adult patients who underwent TLE surgery at Bethel Epilepsy Centre between 1991 and 2002. Results Hippocampal sclerosis was found in 62% of patients, gliosis in 17.3%, tumors in 20%, and focal cortical dysplasia (FCD) in 6.9%. Based on a Kaplan-Meier analysis, the probability of Engel Class I outcome for the patients overall was 76.2% (95% CI 71–81%) at 6 months, 72.3% (95% CI 68–76%) at 2 years, 71.1% (95% CI 67–75%) at 5 years, 70.8% (95% CI 65–75%) at 10 years, and 69.4% (95% CI 64–74%) at 16 years postoperatively. The likelihood of remaining seizure free after 2 years of freedom from seizures was 90% (95% CI 82–98%) for 16 years. Seizure relapse occurred in all subgroups. Patients with FCD had the highest risk of recurrence (hazard ratio 2.15, 95% CI 0.849–5.545). Predictors of remission were the presence of hippocampal atrophy on preoperative MR imaging and a family history of epilepsy. Predictors of relapse were the presence of bilateral interictal sharp waves and versive seizures. Six-month follow-up electroencephalography predicted relapse in patients with FCD. Short epilepsy duration was predictive of seizure remission in patients with tumors and gliosis; 28.1% of patients were able to discontinue antiepileptic medications without an increased risk of seizure recurrence (hazard ratio 1.05, 95% CI 0.933–1.20). Conclusions These findings highlight the role of etiology in prediction of long-term outcome after TLE surgery.


Sign in / Sign up

Export Citation Format

Share Document